• Citer

Enzalutamide for the treatment of androgen receptor-expressing triple-negative breast cancer

par Traina, Tiffany T.A.;Miller, Kathy;Yardley, Denise;Eakle, Janice;Schwartzberg, Lee L.S.;O'Shaughnessy, Joyce;Gradishar, William;Schmid, Peter;Winer, Eric;Kelly, Catherine;Nanda, R.;Gucalp, Ayca;Awada, Ahmad ;Garcia-Estevez, Laura;Trudeau, Maureen Elizabeth;Steinberg, Joyce;Uppal, Hirdesh;Tudor, Iulia Cristina;Peterson, Amy;Cortes, Javier
Référence Journal of clinical oncology, 36, 9, page (884-890)
Publication Publié, 2018

Article révisé par les pairs

• Détails
• Contenu

Titre:	Enzalutamide for the treatment of androgen receptor-expressing triple-negative breast cancer
Auteur:	Traina, Tiffany T.A.; Miller, Kathy; Yardley, Denise; Eakle, Janice; Schwartzberg, Lee L.S.; O'Shaughnessy, Joyce; Gradishar, William; Schmid, Peter; Winer, Eric; Kelly, Catherine; Nanda, R.; Gucalp, Ayca; Awada, Ahmad; Garcia-Estevez, Laura; Trudeau, Maureen Elizabeth; Steinberg, Joyce; Uppal, Hirdesh; Tudor, Iulia Cristina; Peterson, Amy; Cortes, Javier
Informations sur la publication:	Journal of clinical oncology, 36, 9, page (884-890)
Statut de publication:	Publié, 2018
Sujet CREF:	Cancérologie
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2016.71.3495
	info:scp/85044237555